New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.
about
Correlation between in vitro and in vivo activities of GM 237354, a new sordarin derivative, against Candida albicans in an in vitro pharmacokinetic-pharmacodynamic model and influence of protein bindingHigh protein binding and cidal activity against penicillin-resistant S. pneumoniae: a cefditoren in vitro pharmacodynamic simulationComparative pharmacokinetics of cefuroxime lysine after single intravenous, intraperitoneal, and intramuscular administration to rats.Pharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.Assessment of antifungal activities of fluconazole and amphotericin B administered alone and in combination against Candida albicans by using a dynamic in vitro mycotic infection model.In vitro activities of oral beta-lactams at concentrations achieved in humans against penicillin-susceptible and -resistant pneumococci and potential to select resistance.Bacteriological efficacies of three macrolides compared with those of amoxicillin-clavulanate against Streptococcus pneumoniae and Haemophilus influenzae.Evaluation of low-dose, extended-interval clindamycin regimens against Staphylococcus aureus and Streptococcus pneumoniae using a dynamic in vitro model of infectionSimplified dosing of gentamicin for treatment of sepsis in Bangladeshi neonates.What in vitro models of infection can and cannot do.In vitro pharmacokinetic/pharmacodynamic models in anti-infective drug development: focus on TBPharmacokinetics and antibacterial activity of daily gentamicin.Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution modelsKilling activity of cefpirome against penicillin-resistant Streptococcus pneumoniae isolates from patients with meningitis in a pharmacodynamic model simulating the cerebrospinal fluid concentration profile.Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.Antibiotic exposure and its relationship to postantibiotic effect and bactericidal activity: constant versus exponentially decreasing tobramycin concentrations against Pseudomonas aeruginosa.Antibacterial activity of lomefloxacin in a pharmacokinetic in vitro model.Effect of protein binding on serum bactericidal activities of ceftazidime and cefoperazone in healthy volunteersAntipseudomonal activity of simulated infusions of gentamicin alone or with piperacillin assessed by serum bactericidal rate and area under the killing curveCorrection for bacterial loss in in vitro dilution modelsIn vitro evaluation of the determinants of bactericidal activity of ampicillin dosing regimens against Escherichia coliNew in vitro model to study the effect of human simulated antibiotic concentrations on bacterial biofilms.Issues in pharmacokinetics and pharmacodynamics of anti-infective agents: kill curves versus MICKilling of Pseudomonas aeruginosa during continuous and intermittent infusion of ceftazidime in an in vitro pharmacokinetic model.Development of resistance in wild-type and hypermutable Pseudomonas aeruginosa strains exposed to clinical pharmacokinetic profiles of meropenem and ceftazidime simulated in vitro.Pharmacokinetics and pharmacodynamics of nemonoxacin against Streptococcus pneumoniae in an in vitro infection model.A simple in vitro PK/PD model system to determine time-kill curves of drugs against Mycobacteria.A Diffusion-Based and Dynamic 3D-Printed Device That Enables Parallel in Vitro Pharmacokinetic Profiling of MoleculesIn vitro pharmacodynamic models to determine the effect of antibacterial drugs.Impact of dosage schedule of antibiotics on the treatment of serious infections.In vitro studies of pharmacodynamic properties of vancomycin against Staphylococcus aureus and Staphylococcus epidermidisAntibiotic-impregnated heart valve sewing rings for treatment and prophylaxis of bacterial endocarditis.Application of mathematical model to experimental chemotherapy of fatal murine pneumoniaEvaluation of ceftriaxone and other antibiotics against Escherichia coli, Pseudomonas aeruginosa, and Streptococcus pneumoniae under in vitro conditions simulating those of serious infections.Efficacy of intermittent versus continuous administration of netilmicin in a two-compartment in vitro modelKill kinetics and regrowth patterns of Escherichia coli exposed to gentamicin concentration-time profiles simulating in vivo bolus and infusion dosing.Pharmacodynamic effects of subinhibitory concentrations of imipenem on Pseudomonas aeruginosa in an in vitro dynamic model.Influence of albumin on itraconazole and ketoconazole antifungal activity: results of a dynamic in vitro study.Comparative pharmacokinetics of ceforanide (BL-S786R) and cefazolin in laboratory animals and humans.New in vitro kinetic model for evaluating bactericidal efficacy of antibiotics.
P2860
Q28353204-C6C87A8C-5CDD-48BC-BD61-89718A133090Q28473173-D74AC473-2688-45D7-95E0-BF5E90030522Q33571401-9BDC157A-F9B2-4F15-B33B-23083462EC18Q33601794-53029E9A-0A93-4872-9FD2-4BE90AE273E4Q33693370-21674DC6-15CB-4CF1-85BF-00C4988BAD37Q33694789-EE8AC44D-5340-4A2E-8E6B-08FD7D3893E3Q33703410-C76ED624-1AA9-4792-A9A1-C268077CA505Q33977440-F0A2D3BF-1BE7-47A1-A054-96F3614D2C33Q34083485-D06D94A3-E1D6-478F-81A6-DBC75A9B0EA4Q34443398-A5100FA2-2E58-40A4-A828-8453B81AA41AQ34591451-74176B15-6047-400C-910D-8A3C1DC06B55Q35066606-3AD6ED09-17A0-4743-A258-24ED6B2C09BFQ35114219-71DC2D1F-28E2-45B6-8B8C-5BECE9E686FAQ35120392-8298D0C0-4FB8-4CAF-B534-0F337F6933F0Q35128808-891C4005-A581-44D3-9A69-4360898D58D7Q35137815-C23C26EF-B023-4F3C-B1EE-66CE6C2DCBF4Q35260514-ECFF15FE-D250-4DFB-847A-027E702503CBQ35294133-C8F99E8F-0226-460F-A865-E32EBA3774FCQ35348258-E7C04544-735A-497B-80DE-F5D0BA1DAE27Q35543747-73B22C80-9E00-4464-8E3B-9CCFB6A166CEQ35566354-C1AE7A24-371D-4BAF-81F2-57DEEE927C9AQ35616211-A4ED07D1-5D7F-4DF8-BBC8-248304870CE3Q35637864-61E67C8F-768E-4B50-B06A-417D22D2F766Q35820123-4C04AE80-91E8-481B-A745-EED55E6B6EF3Q36095041-97056F46-581B-4513-AC3C-D2872C396A9AQ36969966-6BB368F8-CEAC-463F-A641-D35542BE0818Q37441394-5CDC77E1-CBBF-4190-B573-3BEF418CF70DQ37630801-B766ECC4-9885-4DE7-A832-8F01E535522EQ37660762-27E5D212-63B2-4530-9BBF-DDB928545856Q38035302-F5D0B4C4-4E3F-4CA7-A52F-C6C191C9B8A3Q39559251-EE9A5D37-9A22-4C11-A371-F4AB617544BAQ39782274-EA84B63C-5CD4-4AB7-807C-4C1E82153432Q39815414-E1E679FC-BB88-4F2D-8520-E24E5F3F0AB2Q39818011-889FB9DF-F8F8-4985-8E15-C872759AC847Q39833928-22E94341-0E6B-421D-B811-A4812DF84D28Q39865745-7C2039B5-AF76-4EC9-9E52-2462463756EEQ39867146-D99F1DDF-6C88-4DDB-85D2-E19A7B9CEBCCQ40087660-C08CC732-BA39-4C61-8B31-B52B08762BB8Q40281423-28EDF6D6-2209-4973-80F8-B37D73E9A170Q40282767-F316ECF6-B2ED-48AA-A41E-D89C3950563C
P2860
New in vitro model to study the effect of antibiotic concentration and rate of elimination on antibacterial activity.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
New in vitro model to study th ...... ion on antibacterial activity.
@en
type
label
New in vitro model to study th ...... ion on antibacterial activity.
@en
prefLabel
New in vitro model to study th ...... ion on antibacterial activity.
@en
P2093
P2860
P356
P1476
New in vitro model to study th ...... ion on antibacterial activity.
@en
P2093
Meinardi G
Tamassia V
de Carneri I
P2860
P304
P356
10.1128/AAC.13.4.570
P407
P577
1978-04-01T00:00:00Z